WSJournal: WSJ: ‘Nation Now Has Proof’ of Hillary
WSJournal: WSJ: ‘Nation Now Has Proof’ of Hillary Scandals, But Leftist Media ‘Devote Its Front Pages to the Trump Story’
The Wall Street Journal’s Potomac Watch columnist Kimberley Strassel details the “devastating case against a Clinton presidency” that can be made by reviewing the WikiLeaks documents combined with what is already known in the public record. Strassel notes that although “the nation now has proof of pretty much everything [Hillary Clinton] has been accused of,” the media “has almost uniformly ignored the flurry of bombshells, preferring to devote its front pages” to the story that Donald Trump “made lewd remarks a decade ago and now stands accused of groping women.”
From Strassel in the Wall Street Journal:
The Obama administration—the federal government, supported by tax dollars—was working as an extension of the Clinton campaign. The State Department coordinated with her staff in responding to the email scandal, and the Justice Department kept her team informed about developments in the court case.
Worse, Mrs. Clinton’s State Department, as documents obtained under the Freedom of Information Act show, took special care of donors to the Clinton Foundation. In a series of 2010 emails, a senior aide to Mrs. Clinton asked a foundation official to let her know which groups offering assistance with the Haitian earthquake relief were “FOB” (Friends of Bill) or “WJC VIPs” (William Jefferson Clinton VIPs). Those who made the cut appear to have been teed up for contracts. Those who weren’t? Routed to a standard government website.
The leaks show that the foundation was indeed the nexus of influence and money. The head of the Clinton Health Access Initiative, Ira Magaziner, suggested in a 2011 email that Bill Clinton call Sheikh Mohammed of Saudi Arabia to thank him for offering the use of a plane. In response, a top Clinton Foundation official wrote: “Unless Sheikh Mo has sent us a $6 million check, this sounds crazy to do.
The leaks also show that the press is in Mrs. Clinton’s pocket. Donna Brazile, a former Clinton staffer and a TV pundit, sent the exact wording of a coming CNN town hall question to the campaign in advance of the event. Other media allowed the Clinton camp to veto which quotes they used from interviews, worked to maximize her press events and offered campaign advice.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Bringing Southern Charm to Loudoun We've all seen those places where people parade in with snooty airs and pricetags that could feed a family for a week, but this one feels different. Monkee’s of Loudoun isn’t just rolling in the racks of high fashion — it’s bringing the allure of the South with a sprinkle of luxury and empathy. This franchise is no amateur,...
Continue Reading
SportsMed's Strategic Hoboken Leap The healthcare landscape in New Jersey and Connecticut's about to get a shake-up, and all eyes should be on SportsMed Physical Therapy. They've just planted their flag in Hoboken with a new clinic, bumping their operational presence up to a whopping 57 clinics. Quite the comeback story from their humble beginnings. Now, that's some...
Continue Reading
ServiceTitan Lands in Hot Water Here we go again. News rolled in on September 8, 2026, catching investors like a deer in headlights. ServiceTitan, the operating systems provider that’s been riding the waves of the building and trades industries, just got clobbered with an investigation. As if grappling with their Max AI rollout wasn't enough, Robbins Geller Rudman &...
Continue Reading
An Intriguing Quarter for Rotoplas With third-quarter results rolling in from Grupo Rotoplas S.A.B. de C.V., let's dig into the numbers and see what shook out. These guys topped $2.9 billion in net sales, cruising at a 9.6% increase compared to the same quarter last year. Sure, the headlines might look rosy, but peel back a layer, and you'll see the complexities that...
Continue Reading
A New Milestone in Global Debate The Brewer Foundation is making waves across the debate world, claiming a groundbreaking enrollment for their 2026-27 International Public Policy Forum (IPPF). Let’s talk numbers for a moment—506 teams from a whopping 62 different countries, not to mention new entries from places like France, Mexico, Curaçao, and Russia, all eager to...
Continue Reading
AMTD Digital Warming Up for a Busy Quarter Some things just catch the wind differently in the market, and when a heavyweight like AMTD Digital starts talking numbers, everybody perks up. They're gearing up to drop their half-year financials, ready to roll out at the stroke of midnight on October 23rd, and investor ears across the globe are pricked for what’s coming down...
Continue Reading
Pioneering the Future: WSTDF 2026 in Chongqing In a world where tech buzzwords fly around like confetti at a parade, let's zero in on Chongqing, China, where the 2026 World Science and Technology Development Forum kicked off on October 21. This ain't your typical industry pep rally; it's a gathering of minds ready to swap insights on how today's tech could sculpt...
Continue Reading
When the insurance game gets tough, the tough get smarter with tech. That's the rallying cry behind Convr's latest move into the swirling waters of cyber insurance. Fast-changing, fast-growing, fast-everything—that's the cyber insurance scene these days. With companies fretting over ransomware like they used to worry about office fires, Convr’s stepping up, pumping...
Continue Reading
Redefining the Everyday Athlete Not every day you see a wellness company talking about 'performance' in the broader human sense. Not just for the pros or those beating personal records but for anyone looking to lift the quality of their daily grind. That's the new line LifeWave's drawing in the sand with their spiffy 'Human Performance Technology.' They're looking to...
Continue Reading
Let’s talk about M&T Bank's latest power play in Connecticut. They've tightened their grip on the scene by snapping up naming rights for UConn's Gampel Pavilion. The place isn't just any ol' gym—it's a landmark in college basketball history. This isn't just a flash sponsorship either; it's a full-blown expansion of their partnership with the University of Connecticut....
Continue Reading
Top 5 Most Recently Viewed Articles
Telesat's Upcoming Earnings Conference Call Telesat (Nasdaq and TSX: TSAT), a leading satellite innovator, has announced a conference call scheduled for November 4, 2025, at 10:30 a.m. EST. During this session, the company will present financial results for the three and nine month periods ending September 30, 2025. About the Conference Call Prior to the call, Telesat...
Continue Reading
Latest Developments in BitMine Immersion Technologies BitMine Immersion Technologies Inc (NYSE: BMNR) has made headlines recently as the company's stock price sees an upward trend. This surge can largely be attributed to the company's announcement that it now possesses control over 3.41% of all Ethereum (ETH) in circulation. The Significance of Crypto Holdings As of the...
Continue Reading
3M Company Earnings Update RBC Capital analyst Deane Dray adjusted the price target for 3M Company (NYSE: MMM) from $120 to $130 while maintaining an Underperform rating. This update follows the company's recent earnings report, which revealed some promising results. Recent Earnings Results 3M Company has announced third-quarter adjusted sales of $6.3 billion, slightly...
Continue Reading
WhiteFiber's Successful Public Offering WhiteFiber, Inc. (NASDAQ: WYFI) has triumphantly closed its upsized initial public offering (IPO), marking a significant milestone for the company. This event has captured the attention of investors and stakeholders alike, highlighting WhiteFiber's expanding role in the sector of artificial intelligence infrastructure solutions....
Continue Reading
Aquestive Therapeutics' Anaphylm: A Breakthrough in Allergy Treatments Aquestive Therapeutics, Inc. (NASDAQ: AQST) is making notable advancements with its flagship product, Anaphylm. This innovative, non-injectable epinephrine treatment aims to address severe allergic reactions, and as the company nears crucial regulatory submissions, the pharmaceutical world is taking...
Continue Reading